1. Home
  2. List
  3. Detail

Reference - Detail

RRC ID 66083
Author Sanomachi T, Suzuki S, Kuramoto K, Takeda H, Sakaki H, Togashi K, Seino S, Yoshioka T, Okada M, Kitanaka C.
Title Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents.
Journal Anticancer Res
Volume 37(11)
Pages 6177-6188
Published 2017-11-1
DOI 10.21873/anticanres.12067
PII 37/11/6177
PMID 29061799
MeSH Antineoplastic Agents / pharmacology* Antipsychotic Agents / pharmacology* Apoptosis / drug effects Benzodiazepines / pharmacology* Cell Proliferation / drug effects Drug Resistance, Neoplasm / drug effects* Humans Inhibitor of Apoptosis Proteins / antagonists & inhibitors* Lung Neoplasms / drug therapy* Lung Neoplasms / metabolism Lung Neoplasms / pathology Neoplastic Stem Cells / drug effects* Neoplastic Stem Cells / metabolism Neoplastic Stem Cells / pathology Olanzapine Pancreatic Neoplasms / drug therapy* Pancreatic Neoplasms / metabolism Pancreatic Neoplasms / pathology Survivin Tumor Cells, Cultured
IF 1.994
Altmetric score
オルトメトリクス指標項目
The most frequently cited source Patent(IFI CLAIMS)
Total number of mentions 5
Altmetric score changes over past 6months 0.0
Resource
Human and Animal Cells A549(RCB0098)